Under construction – not a live service
Sign in
Taking people in SpainNo phase

Digital family program for weight control in young people with chronic illness

Tests a digital weight program for young people with obesity and diabetes or asthma.

Plain-language title generated from the registry record
Registry title: DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Key facts

Where
Seville, SpainSee the site

Where in Spain

  • Adhera Health (Virtual Participation)Seville, SpainTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Adhera Health, Inc.
Trial code
NCT07638345
Record updated
23 June 2026
Original description
This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.Read full original descriptionShow less

US-based Clinical Sub-study of DASH-Obesity: Explainable AI for Family-Centric Transdiagnostic Personalized Weight Control Across Multiple Conditions

This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors. A total of 280 families will participate in a 3-month intervention with remote monitoring and follow-up assessments.

Inclusion: Adult caregiver (aged 18 years or older) of an adolescent or young adult aged 12 to 21 years diagnosed with Type 1 Diabetes (T1D) or asthma; The caregiver is actively involved in the management of the adolescent's or young adult's condition; The adolescent or young adult must meet one of the following criteria:; T1D and normal weight (BMI between the 10th and 85th percentile), or; T1D and overweight/obesity (BMI ≥85th percentile), or; Asthma and overweight/obesity (BMI ≥85th percentile); Willingness to participate in the Adhera Caring Digital Program-Obesity (ACDP-O); Access to a smartphone or internet-enabled device compatible with the study application; Willingness to provide self-reported information regarding the adolescent's or young adult's health status, including disease-related and anthropometric measures; For caregivers of participants with T1D, willingness to share continuous glucose monitoring (CGM) information.

Exclusion: Severe psychiatric or cognitive conditions that would interfere with participation in the digital intervention; Current participation in another obesity- or chronic disease-related digital health intervention study; Inability or unwillingness to comply with study procedures; Refusal or inability to provide informed consent.

ClinicalTrials.gov NCT07638345